Correcting X-Linked Disorders: CRISPR/Cas9 for Duchenne Muscular Dystrophy
CRISPR/Cas9 gene editing holds immense therapeutic potential for X-linked disorders like Duchenne muscular dystrophy (DMD). By precisely targeting and correcting disease-causing mutations, this revolutionary technology offers a promising avenue for restoring muscle function and ameliorating the debilitating effects of DMD.